[Everest Medicines] Announcement regarding the expiration of terms for the first Compensation Committee

1. Date of change: 2026/05/22 2. Functional Committee Name: Compensation Committee 3. Name of outgoing members: (1) Luo Bao-Zhu (2) Yang Pan-Jiang (3) Li Shu-Hui (4) Wang Qi-Ming 4. Background of outgoing members: (1) Luo Bao-Zhu, Bachelor of Public Finance, National Chung Hsing University (now National Taipei University), Independent Director of Everest Medicines. (2) Yang Pan-Jiang, Bachelor of Law, National Taiwan University, Independent Director of Everest Medicines. (3) Li Shu-Hui, Ph.D. in Veterinary Medicine, National Chung Hsing University, Independent Director of Everest Medicines. (4) Wang Qi-Ming, Master of Management, University of Houston, USA, Independent Director of Everest Medicines. 5. Name of new members: Not yet appointed 6. Background of new members: Not yet appointed 7. Type of change: Expiration of term 8. Reason for change: Expiration of term 9. Former term: 2023/02/17 to 2026/02/16 10. Effective date for new members: New Compensation Committee members will be appointed at the next board meeting. 11. Other remarks: The term of Compensation Committee members is the same as the term of the Board of Directors that appointed them.